Akèy › Adenom selil ilot › Massachusetts › Boston
Etid klinik pou Adenom selil ilot nan Boston, MA
3 etid pou Adenom selil ilot ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
- Dana-Farber Cancer Institute, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Ap rekriteFaz 3
- Investigative Site, Boston
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Ap rekriteFaz 2
- Massachusetts General Hospital ( Site 0111), Boston
Etid Adenom selil ilot nan lòt vil
- Rochester, MN5 etid
- Los Angeles, CA5 etid
- St. Louis, MO5 etid
- Phoenix, AZ4 etid
- Portland, OR4 etid
- Washington, DC4 etid
- Columbus, OH4 etid
- Salt Lake City, UT4 etid
- Lexington, KY4 etid
- Chicago, IL4 etid
- Jacksonville, FL3 etid
- Irvine, CA3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.